These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 11728683)
1. Long-term urinary function after transperineal brachytherapy for patients with large prostate glands. Sherertz T; Wallner K; Wang H; Sutlief S; Russell K Int J Radiat Oncol Biol Phys; 2001 Dec; 51(5):1241-5. PubMed ID: 11728683 [TBL] [Abstract][Full Text] [Related]
2. Transperineal brachytherapy in patients with large prostate glands. Wang H; Wallner K; Sutlief S; Blasko J; Russell K; Ellis W Int J Cancer; 2000 Aug; 90(4):199-205. PubMed ID: 10993960 [TBL] [Abstract][Full Text] [Related]
3. Urinary morbidity following ultrasound-guided transperineal prostate seed implantation. Gelblum DY; Potters L; Ashley R; Waldbaum R; Wang XH; Leibel S Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):59-67. PubMed ID: 10477007 [TBL] [Abstract][Full Text] [Related]
4. Brachytherapy in patients with small prostate glands. Loblaw DA; Wallner K; Dibiase S; Russell K; Blasko J; Ellis W Tech Urol; 2000 Jun; 6(2):64-9. PubMed ID: 10798802 [TBL] [Abstract][Full Text] [Related]
5. Urinary morbidity with a modified peripheral loading technique of transperineal (125)i prostate implantation. Brown D; Colonias A; Miller R; Benoit R; Cohen J; Arshoun Y; Galloway M; Karlovits S; Wu A; Johnson M; Quinn A; Kalnicki S Int J Radiat Oncol Biol Phys; 2000 May; 47(2):353-60. PubMed ID: 10802359 [TBL] [Abstract][Full Text] [Related]
6. Morbidity effect of the time gap between supplemental beam radiation and Pd-103 prostate brachytherapy. Corriveau J; Wallner K; Merrick G; True L; Cavanagh W; Sutlief S; Butler W Brachytherapy; 2003; 2(2):108-13. PubMed ID: 15062149 [TBL] [Abstract][Full Text] [Related]
8. Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate. Terk MD; Stock RG; Stone NN J Urol; 1998 Oct; 160(4):1379-82. PubMed ID: 9751358 [TBL] [Abstract][Full Text] [Related]
10. Late urinary function after prostate brachytherapy. Landis D; Wallner K; Locke J; Ellis W; Russell K; Cavanagh W; Blasko J Brachytherapy; 2002; 1(1):21-6. PubMed ID: 15062183 [TBL] [Abstract][Full Text] [Related]
11. The effect of supplemental beam radiation on prostate brachytherapy-related morbidity: morbidity outcomes from two prospective randomized multicenter trials. Ghaly M; Wallner K; Merrick G; True L; Sutlief S; Cavanagh W; Butler W Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1288-93. PubMed ID: 12654439 [TBL] [Abstract][Full Text] [Related]
12. Clinical correlates of high intraprostatic brachytherapy dose volumes. Jones S; Wallner K; Merrick G; Corriveau J; Sutlief S; True L; Butler W Int J Radiat Oncol Biol Phys; 2002 Jun; 53(2):328-33. PubMed ID: 12023136 [TBL] [Abstract][Full Text] [Related]
13. Influence of prostate volume on dosimetry results in real-time 125I seed implantation. McNeely LK; Stone NN; Presser J; Chircus JH; Stock RG Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):292-9. PubMed ID: 14697451 [TBL] [Abstract][Full Text] [Related]
14. The utility of transition zone index in predicting acute urinary morbidity after 125I prostate brachytherapy. Crook J; Toi A; McLean M; Pond G Brachytherapy; 2002; 1(3):131-7. PubMed ID: 15090275 [TBL] [Abstract][Full Text] [Related]